Pharma BD Deal Intelligence
Abbott announced a definitive deal to acquire Piramal's Healthcare Solutions business for $2.12 billion upfront plus $400 million annually for four years,…
Business Standard reported Abbott acquiring Piramal's domestic formulations business for $3.7 billion as global drugmakers sought to boost their presence in…
Fierce Pharma reported Abbott completed the Piramal Healthcare Solutions acquisition, becoming the leading pharmaceutical company in India, framing it within…
Source summaries from our enrichment pipeline; follow links for originals.
All 6 sources with sentiment breakdown →
Abbott to acquire Piramal Healthcare's Healthcare Solutions branded generics business for $2.2B upfront + $400M annual installments 2011-2014. Made Abbott #1 pharma in India. Closed September 8, 2010.
Assessment window: 10yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Abbott Laboratories / Piramal Healthcare (Healthcare Solutions Business) (this deal) | 2010 | $3.7B | 55 |
| Abbott Laboratories / Knoll Pharmaceutical Company (BASF Pharma) | 2001 | $6.9B | 100 |
| Abbott Laboratories / Knoll Pharmaceuticals (BASF Pharma) | 2000 | $6.9B | 95 |
| Abbott Laboratories / Alere Inc. | 2016 | $5.8B | 95 |
| Abbott Laboratories / St. Jude Medical | 2016 | $30.5B | 82 |
| Abbott Laboratories / TheraSense Inc. | 2004 | $1.2B | 81 |
| Abbott Laboratories / Vysis Inc. | 2001 | $355M | 79 |
← Browse all deals · How we score deals
More: 2010 deals · Abbott Laboratories deals · Other deals